Molecular Targets and Therapeutics Center
Unser Ziel ist die Entschlüsselung von biologischen Signalwegen und molekularen Mechanismen, die physiologische und krankheitsbezogene zelluläre Prozesse steuern, und damit neue Zielstrukturen zu identifizieren und innovative therapeutische Konzepte zu entwickeln.
Unser Ziel ist die Entschlüsselung von biologischen Signalwegen und molekularen Mechanismen, die physiologische und krankheitsbezogene zelluläre Prozesse steuern, und damit neue Zielstrukturen zu identifizieren und innovative therapeutische Konzepte zu entwickeln.
Unsere Experten für Molekulare Targets und Therapeutika
Highlight Publikationen
2024 Nature Cancer
2023 Signal Transduction and Targeted Therapy
Long-COVID-19: the persisting imprint of SARS-CoV-2 infections on the innate immune system
2023 Nature Structural & Molecular Biology
Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation.
2023 Nat. Commun.
2023 Proc Natl Acad Sci U S A
2023 Molecular Cell
Too big not to fail: Different paths lead to senescence of enlarged cells
2023 Nature Communications
Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis
2023 Nature reviews drug discovery
The therapeutic potential of targeting regulated non-apoptotic cell death.
2023 Nat. Commun.
Structural basis for specific RNA recognition by the alternative splicing factor RBM5
2023 Nucleic Acids Research
Human TRMT2A methylates tRNA and contributes to translation fidelity
2023 Nat. Commun.
2023 Molecular Therapy
Development of a peptide drug restoring AMPK and adipose tissue functionality in cancer cachexia
2023 Nat. Commun.
2023 Nature Cell Biology
2023 Journal of Hepatology
2023 Cancer Treatments Reviews
2023 ACS Applied Materials & Interfaces
2023 Gastroenerology
2023 Nucleic Acids Research
2023 Nucleic Acids Research
2023 Nat Biotechnol.
Neueste Publikationen aus dem MTTC
Weiterlesen2023 Wissenschaftlicher Artikel in Innovative Biosystems and Bioengineering
Antibacterial activity of 1-dodecylpyridinium tetrafluoroborate and its inclusion complex with sulfobutyl ether-β-cyclodextrin against MDR acinetobacter Baumannii strains.
2023 Editorial in Signal transduction and targeted therapy
Long-COVID-19: The persisting imprint of SARS-CoV-2 infections on the innate immune system.
2023 Nature Structural & Molecular Biology